Enterprise DNA

Omni by Enterprise DNA

Enterprise DNA Resources

Latest AI and industry news. Practical AI operating-system thinking for owners, operators, and teams doing real work.

220k+

Data professionals

Omni

AI agents and apps

Audit

Map the manual work

News AI News

Anthropic targets a September/October IPO, ahead of OpenAI

WSJ reports a listing target at roughly a $965B valuation, with OpenAI's own IPO potentially slipping to next year. Early investor meetings are.

Enterprise DNA |
Anthropic targets a September/October IPO, ahead of OpenAI

AI Pulse · Frontier Labs Watch

The play

If you're evaluating Anthropic as a vendor, price in the risk that cheaper Chinese models could compress their margin and your leverage.

Anthropic is apparently eyeing a September or October IPO at a valuation around $965 billion, which would put it on the public markets before OpenAI. That’s according to a Wall Street Journal report making the rounds on social media, though we’re working from a paraphrase rather than the full article.

If the timing holds, it’s a notable shift. OpenAI has been the louder name for longer, but its own listing may now slip into next year. Anthropic, the company behind Claude, has been quieter in the press but aggressive in enterprise deals. A near-trillion-dollar valuation signals investor confidence that it can compete at scale, but early investor meetings are reportedly surfacing two big concerns: cheaper Chinese models eating into margin assumptions, and the political uncertainty around AI regulation and export controls.

For operators, this matters less as a market event and more as a signal about where the frontier lab race is heading. If Anthropic goes public first, it will face quarterly earnings pressure and transparency requirements that OpenAI, still private, can avoid. That could shape product roadmaps, pricing, and how quickly new capabilities roll out to business customers. It also means Anthropic’s enterprise partnerships, support quality, and API reliability will be under sharper scrutiny from shareholders, not just users.

The Chinese competition angle is worth watching. If investors are already pressing on it in private meetings, expect pricing pressure across the board. That’s the kind of shift we track inside the Omni Command Centre, where cost per token and model performance benchmarks feed directly into deployment decisions.

No confirmation yet from Anthropic or the WSJ directly, so treat the timeline as provisional. But if it happens, the IPO will be the first real test of whether a frontier lab can stay frontier while answering to public markets.

Working With Claude field guide cover

Free Resource

Put what you just read to work

The free 32-page Working With Claude guide: the full ecosystem, Claude Code, and how to roll it out across a business.

No spam. Unsubscribe any time.

Free daily email

Get this every morning.

This brief is one item from today's AI Pulse, the short daily read we run for ourselves on what is actually happening in AI. Subscribe free and it lands in your inbox each morning.

Free daily email

Subscribe to the daily AI Pulse

One short read every morning on what is actually happening in AI. Free.

One email a day. Unsubscribe any time.